FRBRX

Franklin Biotechnology Discovery R6

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Franklin Strategic Series - FSS FR Bio-Tech Discovery Class R6 market cap is N/A.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Franklin Strategic Series - FSS FR Bio-Tech Discovery Class R6 52 week high is N/A as of October 10, 2025.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Franklin Strategic Series - FSS FR Bio-Tech Discovery Class R6 52 week low is N/A as of October 10, 2025.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Franklin Strategic Series - FSS FR Bio-Tech Discovery Class R6’s P/E ratio is None.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Franklin Strategic Series - FSS FR Bio-Tech Discovery Class R6 P/B ratio is None.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Franklin Strategic Series - FSS FR Bio-Tech Discovery Class R6's EBITDA is N/A.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Franklin Strategic Series - FSS FR Bio-Tech Discovery Class R6 50-day moving average is N/A.

Franklin Strategic Series - FSS FR Bio-Tech Discovery Class R6 has N/A employees.